These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11461094)

  • 1. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.
    Liu B; Fang M; Lu Y; Lu Y; Mills GB; Fan Z
    Br J Cancer; 2001 Jul; 85(2):303-11. PubMed ID: 11461094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells.
    Boronkai A; Bellyei S; Szigeti A; Pozsgai E; Bognar Z; Sumegi B; Gallyas F
    Eur J Cell Biol; 2009 Dec; 88(12):753-63. PubMed ID: 19717209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
    Fang M; Liu B; Schmidt M; Lu Y; Mendelsohn J; Fan Z
    Anticancer Res; 2000; 20(1A):103-11. PubMed ID: 10769641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines.
    Mabuchi S; Ohmichi M; Kimura A; Nishio Y; Arimoto-Ishida E; Yada-Hashimoto N; Tasaka K; Murata Y
    Endocrinology; 2004 Jan; 145(1):49-58. PubMed ID: 14500571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells.
    Jin W; Wu L; Liang K; Liu B; Lu Y; Fan Z
    Br J Cancer; 2003 Jul; 89(1):185-91. PubMed ID: 12838322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor.
    Caraglia M; Abbruzzese A; Leardi A; Pepe S; Budillon A; Baldassare G; Selleri C; Lorenzo SD; Fabbrocini A; Giuberti G; Vitale G; Lupoli G; Bianco AR; Tagliaferri P
    Cell Death Differ; 1999 Aug; 6(8):773-80. PubMed ID: 10467351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2004 Jul; 25(7):1089-97. PubMed ID: 15001534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells.
    Wang TH; Popp DM; Wang HS; Saitoh M; Mural JG; Henley DC; Ichijo H; Wimalasena J
    J Biol Chem; 1999 Mar; 274(12):8208-16. PubMed ID: 10075725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
    Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts.
    Amato SF; Swart JM; Berg M; Wanebo HJ; Mehta SR; Chiles TC
    Cancer Res; 1998 Jan; 58(2):241-7. PubMed ID: 9443400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of TNF-alpha-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2.
    Bhattacharya S; Ray RM; Johnson LR
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G479-90. PubMed ID: 14563673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK inhibition enhances paclitaxel-induced tumor apoptosis.
    MacKeigan JP; Collins TS; Ting JP
    J Biol Chem; 2000 Dec; 275(50):38953-6. PubMed ID: 11038347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways.
    Ghose A; Fleming J; El-Bayoumy K; Harrison PR
    Cancer Res; 2001 Oct; 61(20):7479-87. PubMed ID: 11606383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
    Zhou J; Gupta K; Yao J; Ye K; Panda D; Giannakakou P; Joshi HC
    J Biol Chem; 2002 Oct; 277(42):39777-85. PubMed ID: 12183452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.
    Yagi H; Yotsumoto F; Sonoda K; Kuroki M; Mekada E; Miyamoto S
    Int J Cancer; 2009 Mar; 124(6):1429-39. PubMed ID: 19048624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
    Park CH; Chung JH
    J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
    Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
    BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.